New cholera drug could cut antibiotic use and hospital stays
NCT ID NCT06193408
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called VR-AD-1005 for treating severe diarrhea caused by cholera. The drug aims to reduce fluid loss and the need for antibiotics, which could help fight antibiotic resistance. 150 adults with cholera took part, and researchers measured stool output and rehydration needs compared to a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLERA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Icddr,b
Dhaka, Bangladesh
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One dose, big hope: antibiotic may stop cholera in kids
- Cholera vaccine ring strategy tested in bangladesh hotspots
- Simple handwashing program could curb cholera outbreaks
- Cholera vaccine vaxchora put to the test in immune response study
- Scientists hunt for cholera protection clues to speed up vaccines
- Soap and sanitation trial aims to slash cholera in congo hotspots